What causes gestational diabetes?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 16, 2025 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Pathophysiology of Gestational Diabetes Mellitus

Gestational diabetes mellitus (GDM) develops primarily due to a combination of pregnancy-induced physiological insulin resistance and inadequate pancreatic β-cell compensation, resulting in maternal hyperglycemia during pregnancy. 1

Dual Mechanisms of Insulin Resistance in GDM

Physiological Insulin Resistance of Pregnancy

  • Normal pregnancy naturally induces insulin resistance that progressively increases with advancing gestation 1, 2
  • Molecular mechanisms include:
    • Alterations at the β-subunit of insulin receptor in skeletal muscle
    • Disruption at insulin receptor substrate-1 (IRS-1) level
    • Increased free intracytoplasmic p85 subunit of phosphatidylinositol 3-kinase
    • These changes reduce insulin-mediated glucose uptake in skeletal muscle 1
  • Pregnancy-specific hormonal factors drive this insulin resistance:
    • Placental growth hormone
    • Tumor necrosis factor-α (TNF-α)
    • Progesterone and estrogen 2
  • This physiological insulin resistance typically resolves within 1 year postpartum 1

Chronic Pre-existing Insulin Resistance

  • Many women with GDM have underlying chronic insulin resistance that predates pregnancy 1
  • This chronic resistance is exacerbated by pregnancy-induced changes
  • Molecular mechanisms include:
    • Decreased maximal insulin receptor tyrosine phosphorylation in muscle
    • Increased serine phosphorylation of insulin receptor and IRS-1
    • These changes further inhibit downstream insulin signaling 1

Pancreatic β-Cell Dysfunction

  • Women who develop GDM have inadequate β-cell compensation for insulin resistance 1, 2
  • They demonstrate lower insulin secretion relative to their degree of insulin resistance 1
  • This β-cell dysfunction represents the critical factor that distinguishes women who develop GDM from those who maintain normal glucose tolerance during pregnancy 1, 2

Placental Factors

  • The placenta serves as the primary interface between mother and fetus 1
  • Placental factors contribute to GDM pathophysiology:
    • Increased expression of cytokines (TNF-α, interleukin-6, leptin)
    • These cytokines may exacerbate insulin resistance 1
  • Placental glucose transport remains normal in GDM pregnancies, but maternal hyperglycemia increases glucose flux to the fetus 1

Genetic Factors

  • Monogenic forms (MODY, mitochondrial diabetes) contribute to approximately 5% of GDM cases 1
  • These genetic variants primarily affect β-cell function 1
  • Women with GDM share similar genetic characteristics with those predisposed to type 2 diabetes 2

Long-term Consequences

  • GDM signals future metabolic risk:
    • Progressive β-cell deterioration over time in relation to chronic insulin resistance 1
    • 50-60% lifetime risk of developing type 2 diabetes 3
    • Increased cardiovascular risk, particularly in the first decade after pregnancy 3

Risk Factors

  • Maternal obesity
  • Advanced maternal age
  • Previous GDM history
  • Family history of type 2 diabetes
  • Certain ethnicities (Arab, South/Southeast Asian, Latin American) 4
  • Birth weight extremes (both high and low) 1

Clinical Implications

  • Early screening is recommended for high-risk women using standard diagnostic criteria 4
  • Lifestyle interventions targeting insulin resistance (diet, physical activity) can reduce progression to diabetes by 35% over 10 years 3
  • Metformin can reduce progression to diabetes by 40% over 10 years 3
  • Regular postpartum glucose testing is essential for early detection of diabetes 3, 4

Understanding the complex pathophysiology of GDM is crucial for effective prevention, early detection, and management to reduce both short-term pregnancy complications and long-term metabolic risks for both mother and child.

References

1
Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

3
Guideline

Management of Offspring Born to Mothers with Gestational Diabetes Mellitus and Polyhydramnios

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

4
Research

[Gestational diabetes mellitus (Update 2023)].

Wiener klinische Wochenschrift, 2023

Related Questions

Why check blood glucose levels at 1, 3, and 6 hours after birth in neonates born to mothers with Gestational Diabetes Mellitus (GDM)?
What is the most appropriate action for a pregnant woman at 20 weeks gestation with no medical complaints and no family history of Gestational Diabetes Mellitus (GDM)?
If an 18-year-old pregnant female with hyperglycemia (elevated blood glucose) and glucosuria (glucose in urine) has an elevated glucose tolerance test, what condition is she at increased risk for developing later in life?
What is the management plan for a 34-week pregnant woman with gestational diabetes mellitus (GDM), oral glucose tolerance test (OGTT) result of 230 mg/dL, and significant glycosuria (urine sugar 4+), should she be admitted?
What is the most appropriate initial screening test for gestational diabetes in a 22-week pregnant woman with a family history of Diabetes Mellitus (DM)?
Can a 58-year-old patient on prazosin (alpha-blocker) for nightmares be given tamsulosin (alpha-blocker) for Benign Prostatic Hyperplasia (BPH)?
What is the recommended approach for diagnosing and treating Benign Prostatic Hyperplasia (BPH)?
What is the initial approach to managing a patient with Abnormal Uterine Bleeding - Anovulatory (AUB-A)?
What are the qualifications for an implantable sleep apnea device?
What is the role of spot urine sodium, sodium-potassium (Na+/K+) ratio, and 24-hour urine sodium in guiding management of decompensated heart failure, and how does Glomerular Filtration Rate (GFR) affect interpretation of these results?
What is the initial treatment approach for late-onset epilepsy?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question